- Home
- CVR vs ERNA Comparison
CVR vs ERNA Comparison
Compare CVR & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVR
- ERNA
- Stock Information
- Founded
- CVR 1920
- ERNA 2018
- Country
- CVR United States
- ERNA United States
- Employees
- CVR N/A
- ERNA N/A
- Industry
- CVR Industrial Machinery/Components
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- CVR Industrials
- ERNA Health Care
- Exchange
- CVR Nasdaq
- ERNA Nasdaq
- Market Cap
- CVR 9.5M
- ERNA 10.2M
- IPO Year
- CVR N/A
- ERNA N/A
- Fundamental
- Price
- CVR $8.76
- ERNA $1.29
- Analyst Decision
- CVR
- ERNA
- Analyst Count
- CVR 0
- ERNA 0
- Target Price
- CVR N/A
- ERNA N/A
- AVG Volume (30 Days)
- CVR 3.1K
- ERNA 11.0M
- Earning Date
- CVR 11-07-2025
- ERNA 11-07-2025
- Dividend Yield
- CVR 1.37%
- ERNA N/A
- EPS Growth
- CVR N/A
- ERNA N/A
- EPS
- CVR N/A
- ERNA N/A
- Revenue
- CVR $26,008,045.00
- ERNA $1,000.00
- Revenue This Year
- CVR N/A
- ERNA N/A
- Revenue Next Year
- CVR N/A
- ERNA N/A
- P/E Ratio
- CVR N/A
- ERNA N/A
- Revenue Growth
- CVR N/A
- ERNA N/A
- 52 Week Low
- CVR $8.15
- ERNA $1.09
- 52 Week High
- CVR $19.00
- ERNA $14.40
- Technical
- Relative Strength Index (RSI)
- CVR 39.85
- ERNA 39.58
- Support Level
- CVR $8.76
- ERNA $1.21
- Resistance Level
- CVR $9.05
- ERNA $1.84
- Average True Range (ATR)
- CVR 0.31
- ERNA 0.11
- MACD
- CVR 0.01
- ERNA -0.05
- Stochastic Oscillator
- CVR 20.80
- ERNA 10.50
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.